Back to Authors

Cockerill, Franklin R.

A5028896212 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 58

Clinical Evaluation of the Gen-Probe Amplified Direct Test for Detection of Mycobacterium tuberculosis Complex Organisms in Cerebrospinal Fluid

Journal of Clinical Microbiology | December 31, 2019 | Volume: 36 | Issue: 8 | Pages: 2191-2194

10.1128/jcm.36.8.2191-2194.1998 | PMID 9665989

ABSTRACT Eighty-four cerebrospinal fluid (CSF) samples from different children who presented with signs and symptoms of meningitis were evaluated for the presence of Mycobacterium tuberculosis complex organisms by the Gen-Probe Amplified Mycobacterium tuberculosis Direct Test (MTD; Gen-Probe, San Diego, Calif.). All CSF samples had negative acid-fast smears by the Ziehl-Neelsen staining method. M. tuberculosis was recovered from five samples. M. tuberculosis did not grow from 19 additional samples, but the samples were from patients who fulfilled specific clinical and laboratory criteria for probable tuberculous meningitis (TBM). The remaining samples ( n = 60) were from patients with other infections or noninfectious causes of meningitis. The results of the MTD were interpreted as positive or negative on the basis of recommended cutoff values for respiratory specimens. These results were interpreted as true or false positives or true or false negatives on the basis of the results of M. tuberculosis culture or whether the patient fulfilled criteria for probable TBM. The Gen-Probe MTD was 33% sensitive and 100% specific for detecting M. tuberculosis complex organisms in these 84 CSF samples. If the cutoff values for positive results were decreased for the MTD (≥11,000 versus ≥30,000 relative light units), the sensitivity increased to 83% and the specificity remained 100%. These results for the MTD are encouraging considering that TBM is a highly fatal disease and difficult to diagnose by conventional laboratory techniques.
Determination of 16S rRNA Sequences of Enterococci and Application to Species Identification of Nonmotile Enterococcus gallinarum Isolates

Journal of Clinical Microbiology | December 31, 2019 | Volume: 36 | Issue: 11 | Pages: 3399-3407

10.1128/jcm.36.11.3399-3407.1998 | PMID 9774606

ABSTRACT The 16S rRNA sequences of enterococcal species E. faecium , E. faecalis , E. gallinarum , E. casseliflavus/flavescens , E. dispar , E. pseudoavium , E. sulfureus , E. malodoratus , E. raffinosus , E. cecorum , E. hirae , E. saccharolyticus , E. seriolicida , E. mundtii , E. avium , E. durans , E. columbae , and E. solitarius are presented herein. These data were utilized to confirm the species identification of two nonmotile E. gallinarum isolates which had been previously phenotypically identified as E. faecium . The implications of this finding are discussed.
Genetic Methods for Assessing Antimicrobial Resistance

Antimicrobial Agents and Chemotherapy | October 9, 2018 | Volume: 43 | Issue: 2 | Pages: 199-212

10.1128/aac.43.2.199 | PMID 9925507

DNA Sequence Variation within vanA , vanB , vanC-1 , and vanC-2/3 Genes of Clinical Enterococcus Isol

Antimicrobial Agents and Chemotherapy | October 9, 2018 | Volume: 42 | Issue: 1 | Pages: 202-205

10.1128/aac.42.1.202 | PMID 9449290

ABSTRACT We studied the DNA sequence variation of van genes of 34 isolates of Enterococcus spp. The isolates containing the vanB gene exhibited between 0 and 41 base pair changes per 801 bp studied when the vanB sequences were compared to that of the reference strain Enterococcus faecalis V583. The isolates carrying the vanC-2 gene exhibited between 0 and 23 base pair changes per 346 bp studied when the vanC-2 sequences were compared to that of the reference strain E. casseliflavus ATCC 25788. Little variation was noted in the vanA and vanC-1 genes.
Fungal infections of the immunocompromised host: clinical and laboratory aspects

Clinical Microbiology Reviews | June 2, 2016 | Volume: 1 | Issue: 4 | Pages: 349-364

10.1128/cmr.1.4.349 | PMID 3069198

Fungal infections of the immunocompromised host are being seen with greater frequency than ever before. In addition, a growing list of unusual and unexpected etiologic agents presents a unique and difficult challenge to the clinician and microbiologist. The clinical manifestations of opportunistic fungal infections are often not characteristic and, in many instances, may prevent a rapid diagnosis from being made. Clinical microbiology laboratories should consider any organism as a potential etiologic agent. This requires that all fungi recovered from immunocompromised patients be thoroughly identified and reported so that their clinical significance may be assessed. This review presents a brief discussion of the clinical and laboratory aspects of some fungal infections seen in this important group of patients.
Next Generation Sequencing in Clinical Diagnostics: Experiences of Early Adopters

Clinical Chemistry | November 24, 2014 | Volume: 61 | Issue: 1 | Pages: 41-49

10.1373/clinchem.2014.222687 | PMID 25421800

Inhibition Controls for Qualitative Real-Time PCR Assays: Are They Necessary for All Specimen Matrices?

Journal of Clinical Microbiology | April 16, 2014 | Volume: 52 | Issue: 6 | Pages: 2139-2143

10.1128/jcm.03389-13 | PMID 24740078

ABSTRACT A retrospective analysis of 386,706 specimens representing a variety of matrix types used in qualitative real-time PCR assays determined the overall inhibition rate to be 0.87% when the inhibition control was added preextraction to 5,613 specimens and 0.01% when the inhibition control was added postextraction but preamplification in 381,093 specimens. Inhibition rates of ≤1% were found for all specimen matrix types except urine and formalin-fixed, paraffin-embedded tissue.
PCR-Electrospray Ionization Mass Spectrometry for Direct Detection of Pathogens and Antimicrobial Resistance from Heart Valves in Patients with Infective Endocarditis

Journal of Clinical Microbiology | April 18, 2013 | Volume: 51 | Issue: 7 | Pages: 2040-2046

10.1128/jcm.00304-13 | PMID 23596241

ABSTRACT Microbiological diagnosis is pivotal to the appropriate management and treatment of infective endocarditis. We evaluated PCR-electrospray ionization mass spectrometry (PCR/ESI-MS) for bacterial and candidal detection using 83 formalin-fixed paraffin-embedded heart valves from subjects with endocarditis who had positive valve and/or blood cultures, 63 of whom had positive valvular Gram stains. PCR/ESI-MS yielded 55% positivity with concordant microbiology at the genus/species or organism group level (e.g., viridans group streptococci), 11% positivity with discordant microbiology, and 34% with no detection. PCR/ESI-MS detected all antimicrobial resistance encoded by mecA or vanA / B and identified a case of Tropheryma whipplei endocarditis not previously recognized.
Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Systems for Identification of Nonfermenting Gram-Negative Bacilli Isolated from Cultures from Cystic Fibrosis Patients

Journal of Clinical Microbiology | April 12, 2012 | Volume: 50 | Issue: 6 | Pages: 2034-2039

10.1128/jcm.00330-12 | PMID 22495566

ABSTRACTThe Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry (MS) instruments were evaluated for the identification of nonfermenting Gram-negative bacilli (NFGNB) by a blinded comparison to conventional biochemical or molecular methods. Two hundred NFGNB that were recovered from cultures from cystic fibrosis patients in the University of Iowa Health Care (UIHC) Microbiology Laboratory between 1 January 2006 and 31 October 2010 were sent to Mayo Clinic for analysis with the Bruker Biotyper (software version 3.0) and to bioMérieux for testing with Vitek MS (SARAMIS database version 3.62). If two attempts at direct colony testing failed to provide an acceptable MALDI-TOF identification, an extraction procedure was performed. The MS identifications from both of these systems were provided to UIHC for comparison to the biochemical or molecular identification that had been reported in the patient record. Isolates with discordant results were analyzed by 16S rRNA gene sequencing at UIHC. After discrepancy testing, the Bruker Biotyper result agreed with the biochemical or molecular method, with 72.5% of isolates to the species level, 5.5% to the complex level, and 19% to the genus level (3% not identified). The level of agreement for Vitek MS was 80% species, 3.5% complex, 6% genus, and 3.5% family (7% not identified). Both MS systems provided rapid (≤3 min per isolate) and reliable identifications. The agreement of combined species/complex/genus-level identification with the reference method was higher for the Bruker Biotyper (97% versus 89.5%,P= 0.004) but required an extraction step more often. Species-level agreement with the reference method was similar for both MS systems (72.5% and 80%,P= 0.099).
Detection of Smallpox Virus DNA by LightCycler PCR

Journal of Clinical Microbiology | December 8, 2011 | Volume: 40 | Issue: 11 | Pages: 4405-4405

10.1128/jcm.40.11.4405.2002-a